Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1993 Jul 3;307(6895):35–41. doi: 10.1136/bmj.307.6895.35

Acute circulatory support.

M J Barnard 1, S P Linter 1
PMCID: PMC1678508  PMID: 8267717

Abstract

Numerous drugs can increase cardiac output, thereby improving tissue oxygen delivery, but often they do this at the expense of increasing myocardial oxygen demand. This may be critical when cardiac function is substantially impaired or ischaemia is the precipitating cause. Using polypharmacy to substantially improve cardiovascular status requires detailed knowledge of the pharmacodynamics and interactions of the available agents so that they may be tailored to the individual patient. In some settings combinations of inotropes and vasodilators may be desirable to minimise cardiac workload. In other instances vasopressors may be necessary to urgently restore a minimum perfusion pressure. This paper reviews the use of this group of drugs as well as the mechanical assist devices that may be used when drugs fail.

Full text

PDF
35

Images in this article

39FIG 2
on p.39

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alderman J. D., Gabliani G. I., McCabe C. H., Brewer C. C., Lorell B. H., Pasternak R. C., Skillman J. J., Steer M. L., Baim D. S. Incidence and management of limb ischemia with percutaneous wire-guided intraaortic balloon catheters. J Am Coll Cardiol. 1987 Mar;9(3):524–530. doi: 10.1016/s0735-1097(87)80044-x. [DOI] [PubMed] [Google Scholar]
  2. American Lung Association, American Thoracic Society, International Union against Tuberculosis and Lung Disease. Abstracts. 1990 World Conference on Lung Health. May 20-24, 1990, Boston, Massachusetts. Am Rev Respir Dis. 1990 Apr;141(4 Pt 2):A1–977. [PubMed] [Google Scholar]
  3. Bass A. S. Contrasting effects of dopexamine hydrochloride on electrolyte excretion in canine kidney. J Pharmacol Exp Ther. 1990 May;253(2):798–802. [PubMed] [Google Scholar]
  4. Binkley P. F., Murray K. D., Watson K. M., Myerowitz P. D., Leier C. V. Dobutamine increases cardiac output of the total artificial heart. Implications for vascular contribution of inotropic agents to augmented ventricular function. Circulation. 1991 Sep;84(3):1210–1215. doi: 10.1161/01.cir.84.3.1210. [DOI] [PubMed] [Google Scholar]
  5. Boldt J., Knothe C., Zickmann B., Ballesteros M., Russ W., Dapper F., Hempelmann G. The role of enoximone in cardiac surgery. Br J Anaesth. 1992 Jul;69(1):45–50. doi: 10.1093/bja/69.1.45. [DOI] [PubMed] [Google Scholar]
  6. Bristow M. R., Ginsburg R., Minobe W., Cubicciotti R. S., Sageman W. S., Lurie K., Billingham M. E., Harrison D. C., Stinson E. B. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982 Jul 22;307(4):205–211. doi: 10.1056/NEJM198207223070401. [DOI] [PubMed] [Google Scholar]
  7. Colucci W. S. Cardiovascular effects of milrinone. Am Heart J. 1991 Jun;121(6 Pt 2):1945–1947. doi: 10.1016/0002-8703(91)90829-7. [DOI] [PubMed] [Google Scholar]
  8. Curfman G. D. Inotropic therapy for heart failure--an unfulfilled promise. N Engl J Med. 1991 Nov 21;325(21):1509–1510. doi: 10.1056/NEJM199111213252111. [DOI] [PubMed] [Google Scholar]
  9. D'Ambra M. N., LaRaia P. J., Philbin D. M., Watkins W. D., Hilgenberg A. D., Buckley M. J. Prostaglandin E1. A new therapy for refractory right heart failure and pulmonary hypertension after mitral valve replacement. J Thorac Cardiovasc Surg. 1985 Apr;89(4):567–572. [PubMed] [Google Scholar]
  10. Dage R. C., Okerholm R. A. Pharmacology and pharmacokinetics of enoximone. Cardiology. 1990;77 (Suppl 3):2–33. doi: 10.1159/000174664. [DOI] [PubMed] [Google Scholar]
  11. Daniel M. A., Lee J., LaForge D. H., Chen H., Billich J., Miller P. J., Ramasamy N., Strauss L. R., Jassawalla J. S., Portner P. M. Clinical evaluation of the Novacor totally implantable ventricular assist system. Current status. ASAIO Trans. 1991 Jul-Sep;37(3):M423–M425. [PubMed] [Google Scholar]
  12. DiBianco R. Acute positive inotropic intervention: the phosphodiesterase inhibitors. Am Heart J. 1991 Jun;121(6 Pt 1):1871–1875. doi: 10.1016/0002-8703(91)90078-v. [DOI] [PubMed] [Google Scholar]
  13. DiBianco R., Shabetai R., Kostuk W., Moran J., Schlant R. C., Wright R. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med. 1989 Mar 16;320(11):677–683. doi: 10.1056/NEJM198903163201101. [DOI] [PubMed] [Google Scholar]
  14. Farrar D. J., Hill J. D. Univentricular and biventricular Thoratec VAD support as a bridge to transplantation. Ann Thorac Surg. 1993 Jan;55(1):276–282. doi: 10.1016/0003-4975(93)90537-r. [DOI] [PubMed] [Google Scholar]
  15. Francis G. S. Vasodilators in the intensive care unit. Am Heart J. 1991 Jun;121(6 Pt 1):1875–1878. doi: 10.1016/0002-8703(91)90079-w. [DOI] [PubMed] [Google Scholar]
  16. Ghosh S., Gray B., Oduro A., Latimer R. D. Dopexamine hydrochloride: pharmacology and use in low cardiac output states. J Cardiothorac Vasc Anesth. 1991 Aug;5(4):382–389. doi: 10.1016/1053-0770(91)90166-q. [DOI] [PubMed] [Google Scholar]
  17. Gillespie T. A., Ambos H. D., Sobel B. E., Roberts R. Effects of dobutamine in patients with acute myocardial infarction. Am J Cardiol. 1977 Apr;39(4):588–594. doi: 10.1016/s0002-9149(77)80170-7. [DOI] [PubMed] [Google Scholar]
  18. Gutierrez G., Palizas F., Doglio G., Wainsztein N., Gallesio A., Pacin J., Dubin A., Schiavi E., Jorge M., Pusajo J. Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet. 1992 Jan 25;339(8787):195–199. doi: 10.1016/0140-6736(92)90002-k. [DOI] [PubMed] [Google Scholar]
  19. Hajjar R. J., Gwathmey J. K. Calcium-sensitizing inotropic agents in the treatment of heart failure: a critical view. Cardiovasc Drugs Ther. 1991 Dec;5(6):961–965. doi: 10.1007/BF00143520. [DOI] [PubMed] [Google Scholar]
  20. Harrison S. A., Reifsnyder D. H., Gallis B., Cadd G. G., Beavo J. A. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs. Mol Pharmacol. 1986 May;29(5):506–514. [PubMed] [Google Scholar]
  21. Johnson K. E., Liska M. B., Joyce L. D., Emery R. W. Registry report. Use of total artificial hearts: summary of world experience, 1969-1991. ASAIO J. 1992 Jul-Sep;38(3):M486–M492. [PubMed] [Google Scholar]
  22. Kantrowitz A., Freed P. S., Cardona R. R., Gage K., Marinescu G. N., Westveld A. H., Litch B., Suzuki A., Hayakawa H., Takano T. Initial clinical trial of a closed loop, fully automatic intra-aortic balloon pump. ASAIO J. 1992 Jul-Sep;38(3):M617–M621. doi: 10.1097/00002480-199207000-00110. [DOI] [PubMed] [Google Scholar]
  23. Konstam M. A., Cohen S. R., Weiland D. S., Martin T. T., Das D., Isner J. M., Salem D. N. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure. Am J Cardiol. 1986 Feb 1;57(4):242–248. doi: 10.1016/0002-9149(86)90899-4. [DOI] [PubMed] [Google Scholar]
  24. Leier C. V., Binkley P. F. Acute positive inotropic intervention: the catecholamines. Am Heart J. 1991 Jun;121(6 Pt 1):1866–1870. doi: 10.1016/0002-8703(91)90077-u. [DOI] [PubMed] [Google Scholar]
  25. Leier C. V., Binkley P. F., Carpenter J., Randolph P. H., Unverferth D. V. Cardiovascular pharmacology of dopexamine in low output congestive heart failure. Am J Cardiol. 1988 Jul 1;62(1):94–99. doi: 10.1016/0002-9149(88)91371-9. [DOI] [PubMed] [Google Scholar]
  26. Lemmer J. H., Botham M. J., McKenney P., Gerren R. A., Kirsh M. M., Gallagher K. P. Norepinephrine plus phentolamine improves regional blood flow during experimental low cardiac output syndrome. Ann Thorac Surg. 1984 Aug;38(2):108–116. doi: 10.1016/s0003-4975(10)62215-1. [DOI] [PubMed] [Google Scholar]
  27. Liska M. B., Johnson K. E., Emery R. W. Current functional status of Symbion total artificial heart recipients after transplantation. ASAIO J. 1992 Oct-Dec;38(4):804–807. [PubMed] [Google Scholar]
  28. Löllgen H., Drexler H. Use of inotropes in the critical care setting. Crit Care Med. 1990 Jan;18(1 Pt 2):S56–S60. [PubMed] [Google Scholar]
  29. Maccioli G A, Lucas W J, Norfleet E A. The intra-aortic balloon pump: a review. J Cardiothorac Anesth. 1988 Jun;2(3):365–373. doi: 10.1016/0888-6296(88)90320-1. [DOI] [PubMed] [Google Scholar]
  30. Marks J. D., Karwande S. V., Richenbacher W. E., Jones K. W., Doty D. B., Millar R. C., O'Connell J. B., Renlund D. G., Bristow M. R., Pantalos G. M. Perioperative mechanical circulatory support for transplantation. J Heart Lung Transplant. 1992 Jan-Feb;11(1 Pt 1):117–128. [PubMed] [Google Scholar]
  31. McCarthy P. M., Portner P. M., Tobler H. G., Starnes V. A., Ramasamy N., Oyer P. E. Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application. J Thorac Cardiovasc Surg. 1991 Oct;102(4):578–587. [PubMed] [Google Scholar]
  32. Miller L. W. Mechanical assist devices in intensive cardiac care. Am Heart J. 1991 Jun;121(6 Pt 1):1887–1892. doi: 10.1016/0002-8703(91)90081-r. [DOI] [PubMed] [Google Scholar]
  33. Moore C. H., Dailey J. W., Canon D. S., Rubin J. M. Non-pulsatile circulatory support in 90 cases. ASAIO J. 1992 Jul-Sep;38(3):M627–M630. doi: 10.1097/00002480-199207000-00112. [DOI] [PubMed] [Google Scholar]
  34. Mulcahy D., Fitzgerald M., Wright C., Sparrow J., Pepper J., Yacoub M., Fox K. M. Long term follow up of severely ill patients who underwent urgent cardiac transplantation. BMJ. 1993 Jan 9;306(6870):98–101. doi: 10.1136/bmj.306.6870.98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Murali S., Uretsky B. F., Reddy P. S., Tokarczyk T. R., Betschart A. R. Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: comparative effects of various pharmacologic agents. Am Heart J. 1991 Nov;122(5):1375–1381. doi: 10.1016/0002-8703(91)90580-b. [DOI] [PubMed] [Google Scholar]
  36. Murphy M. B., Elliott W. J. Dopamine and dopamine receptor agonists in cardiovascular therapy. Crit Care Med. 1990 Jan;18(1 Pt 2):S14–S18. [PubMed] [Google Scholar]
  37. Olsen K. H., Kluger J., Fieldman A. Combination high dose amrinone and dopamine in the management of moribund cardiogenic shock after open heart surgery. Chest. 1988 Sep;94(3):503–506. doi: 10.1378/chest.94.3.503. [DOI] [PubMed] [Google Scholar]
  38. Ott R. A., Mills T. C., Eugene J., Gazzaniga A. B. Clinical choices for circulatory assist devices. ASAIO Trans. 1990 Oct-Dec;36(4):792–798. doi: 10.1097/00002480-199010000-00003. [DOI] [PubMed] [Google Scholar]
  39. Packer M., Carver J. R., Rodeheffer R. J., Ivanhoe R. J., DiBianco R., Zeldis S. M., Hendrix G. H., Bommer W. J., Elkayam U., Kukin M. L. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med. 1991 Nov 21;325(21):1468–1475. doi: 10.1056/NEJM199111213252103. [DOI] [PubMed] [Google Scholar]
  40. Pae W. E., Jr Ventricular assist devices and total artificial hearts: a combined registry experience. Ann Thorac Surg. 1993 Jan;55(1):295–298. doi: 10.1016/0003-4975(93)90540-x. [DOI] [PubMed] [Google Scholar]
  41. Pinsky M. R., Summer W. R., Wise R. A., Permutt S., Bromberger-Barnea B. Augmentation of cardiac function by elevation of intrathoracic pressure. J Appl Physiol Respir Environ Exerc Physiol. 1983 Apr;54(4):950–955. doi: 10.1152/jappl.1983.54.4.950. [DOI] [PubMed] [Google Scholar]
  42. Poirier V. The quest for the permanent LVAD. We must continue, we must push forward. ASAIO Trans. 1990 Oct-Dec;36(4):787–788. [PubMed] [Google Scholar]
  43. Pritchett E. L., Smith M. S., McCarthy E. A., Lee K. L. The spontaneous occurrence of paroxysmal supraventricular tachycardia. Circulation. 1984 Jul;70(1):1–6. doi: 10.1161/01.cir.70.1.1. [DOI] [PubMed] [Google Scholar]
  44. Pucéat M., Terzic A., Clément O., Scamps F., Vogel S. M., Vassort G. Cardiac alpha 1-adrenoceptors mediate positive inotropy via myofibrillar sensitization. Trends Pharmacol Sci. 1992 Jul;13(7):263–265. doi: 10.1016/0165-6147(92)90080-p. [DOI] [PubMed] [Google Scholar]
  45. Reedy J. E., Pennington D. G., Miller L. W., McBride L. R., Lohmann D. P., Noedel N. R., Swartz M. T. Status I heart transplant patients: conventional versus ventricular assist device support. J Heart Lung Transplant. 1992 Mar-Apr;11(2 Pt 1):246–252. [PubMed] [Google Scholar]
  46. Reedy J. E., Swartz M. T., Lohmann D. P., Moroney D. A., Vaca K. J., McBride L. R., Pennington D. G. The importance of patient mobility with ventricular assist device support. ASAIO J. 1992 Jul-Sep;38(3):M151–M153. doi: 10.1097/00002480-199207000-00007. [DOI] [PubMed] [Google Scholar]
  47. Robinson R. J., Tchervenkov C. Treatment of low cardiac output after aortocoronary artery bypass surgery using a combination of norepinephrine and amrinone. J Cardiothorac Anesth. 1987 Jun;1(3):229–233. doi: 10.1016/s0888-6296(87)80009-1. [DOI] [PubMed] [Google Scholar]
  48. Ruffolo R. R., Jr, Spradlin T. A., Pollock G. D., Waddell J. E., Murphy P. J. Alpha and beta adrenergic effects of the stereoisomers of dobutamine. J Pharmacol Exp Ther. 1981 Nov;219(2):447–452. [PubMed] [Google Scholar]
  49. Schaer G. L., Fink M. P., Parrillo J. E. Norepinephrine alone versus norepinephrine plus low-dose dopamine: enhanced renal blood flow with combination pressor therapy. Crit Care Med. 1985 Jun;13(6):492–496. doi: 10.1097/00003246-198506000-00011. [DOI] [PubMed] [Google Scholar]
  50. Shoemaker W. C., Appel P. L., Kram H. B. Oxygen transport measurements to evaluate tissue perfusion and titrate therapy: dobutamine and dopamine effects. Crit Care Med. 1991 May;19(5):672–688. doi: 10.1097/00003246-199105000-00014. [DOI] [PubMed] [Google Scholar]
  51. Tanaka K., Sato T., Kondo C., Yada I., Yuasa H., Kusagawa M., Nasu M., Okada Y., Shomura T. Hematological problems during the use of cardiac assist devices: clinical experiences in Japan. Artif Organs. 1992 Apr;16(2):182–188. doi: 10.1111/j.1525-1594.1992.tb00291.x. [DOI] [PubMed] [Google Scholar]
  52. Tuttle R. R., Pollock G. D., Todd G., MacDonald B., Tust R., Dusenberry W. The effect of dobutamine on cardiac oxygen balance, regional blood flow, and infarction severity after coronary artery narrowing in dogs. Circ Res. 1977 Sep;41(3):357–364. doi: 10.1161/01.res.41.3.357. [DOI] [PubMed] [Google Scholar]
  53. Uretsky B. F., Hua J. Combined intravenous pharmacotherapy in the treatment of patients with decompensated congestive heart failure. Am Heart J. 1991 Jun;121(6 Pt 1):1879–1886. doi: 10.1016/0002-8703(91)90080-2. [DOI] [PubMed] [Google Scholar]
  54. Uretsky B. F., Lawless C. E., Verbalis J. G., Valdes A. M., Kolesar J. A., Reddy P. S. Combined therapy with dobutamine and amrinone in severe heart failure. Improved hemodynamics and increased activation of the renin-angiotensin system with combined intravenous therapy. Chest. 1987 Oct;92(4):657–662. doi: 10.1378/chest.92.4.657. [DOI] [PubMed] [Google Scholar]
  55. Vincent J. L., Léon M., Berré J., Mélot C., Kahn R. J. Addition of enoximone to adrenergic agents in the management of severe heart failure. Crit Care Med. 1992 Aug;20(8):1102–1106. doi: 10.1097/00003246-199208000-00006. [DOI] [PubMed] [Google Scholar]
  56. Vincent J. L., Léon M., Berré J. The role of enoximone in the treatment of cardiogenic shock. Cardiology. 1990;77 (Suppl 3):21–33. doi: 10.1159/000174667. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES